annb0t
Top 20
ResMed Inc.âs RMD adjusted earnings per share (EPS) in the third quarter of fiscal 2022 were $1.32, up 1.5% year over year. However, the metric lagged the Zacks Consensus Estimate by 8.3%.
The adjustments include certain non-recurring expenses/benefits like amortization of acquired intangibles and restructuring costs, among others.
The ongoing recovery of core patient flow across the companyâs business and the provision of sleep apnea therapy, respiratory care therapy and digital hea...
>>> Read more: ResMed (RMD) Q3 Earnings Miss Estimates, Margins Decline
The adjustments include certain non-recurring expenses/benefits like amortization of acquired intangibles and restructuring costs, among others.
The ongoing recovery of core patient flow across the companyâs business and the provision of sleep apnea therapy, respiratory care therapy and digital hea...
>>> Read more: ResMed (RMD) Q3 Earnings Miss Estimates, Margins Decline
